Biochemotherapy With Temozolomide, Velban, Cisplatin, Interleukin-2, Interferon-Alpha and Thalidomide for Metastatic Melanoma With Optional Intrathecal Interleukin-2 Treatment.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Interferon alpha; Interleukin-2; Temozolomide; Thalidomide; Vinblastine
- Indications Malignant melanoma
- Focus Therapeutic Use
- 24 Sep 2020 Biomarkers information updated
- 14 Apr 2010 Actual number of patients (5) added as reported by ClinicalTrials.gov record.
- 14 Apr 2010 Planned end date changed from 1 Mar 2010 to 1 Apr 2010 as reported by ClinicalTrials.gov.